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Two decades after the discovery of the first animal microRNA
(miRNA), the number of miRNAs in animal genomes remains a vexing
question. Here, we report findings from analyzing 1,323 short RNA
sequencing samples (RNA-seq) from 13 different human tissue types.
Using stringent thresholding criteria, we identified 3,707 statistically
significant novel mature miRNAs at a false discovery rate of ≤0.05
arising from3,494novelprecursors; 91.5%of thesenovelmiRNAswere
identified independently in 10 ormore of the processed samples. Anal-
ysis of these novel miRNAs revealed tissue-specific dependencies and
a commensurate low Jaccard similarity index in intertissue compari-
sons.Of thesenovelmiRNAs,1,657 (45%)were identified in43datasets
thatwere generated by cross-linking followed byArgonaute immuno-
precipitation and sequencing (Ago CLIP-seq) and represented 3 of the
13 tissues, indicating that thesemiRNAs are active in the RNA interfer-
ence pathway. Moreover, experimental investigation through stem-
loop PCR of a random collection of newly discoveredmiRNAs in 12 cell
lines representing 5 tissues confirmed their presence and tissue depen-
dence. Among the newly identified miRNAs are many novel miRNA
clusters, new members of known miRNA clusters, previously unre-
ported products from uncharacterized arms of miRNA precursors, and
previously unrecognized paralogues of functionally important miRNA
families (e.g., miR-15/107). Examination of the sequence conservation
across vertebrate and invertebrate organisms showed 56.7% of the
newly discovered miRNAs to be human-specific whereas the ma-
jority (94.4%) are primate lineage-specific. Our findings suggest that
the repertoire of human miRNAs is far more extensive than currently
representedbypublic repositoriesandthatthere isasignificantnumber
of lineage- and/or tissue-specific miRNAs that are uncharacterized.
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MicroRNAs (miRNAs) are small, single-stranded RNAs witha length of ∼22 nt that are typically derived from endoge-
nous hairpin transcripts. MiRNAs interact with their targeted RNA
in a sequence-dependent manner (1, 2), thereby functioning as
posttranscriptional regulators of gene expression. Regulation of the
targeted RNAs is achieved through several mechanisms, including
translational inhibition (3), disruption of cap–tail interactions (4, 5),
and exonuclease-mediated mRNA degradation (6, 7).
Significance
MicroRNAs (miRNAs) are small ∼22-nt RNAs that are important
regulators of posttranscriptional gene expression. Since their
initial discovery, they have been shown to be involved in many
cellular processes, and their misexpression is associated with
disease etiology. Currently, nearly 2,800 human miRNAs are
annotated in public repositories. A key question in miRNA re-
search is how many miRNAs are harbored by the human ge-
nome. To answer this question, we examined 1,323 short RNA
sequence samples and identified 3,707 novel miRNAs, many
of which are human-specific and tissue-specific. Our findings
suggest that the human genome expresses a greater number of
miRNAs than has previously been appreciated and that many
more miRNA molecules may play key roles in disease etiology.
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Originally believed to regulate messenger RNAs (mRNAs) solely
through interactions with the 3′ untranslated region (3′ UTR) (1),
miRNAs are now known to have a very broad set of targets. These
targets include loci in the protein-coding region of mRNAs (8–13),
5′ UTRs (14), intronic and intergenic transcripts (15, 16), and other
non–protein-coding RNAs (ncRNAs) (17, 18), as well as embedded
B retroelements (13, 19), pseudogenes (20), short interspersed
elements (SINEs) (21), and circular RNAs (22, 23). As technolog-
ical and research advances reveal a larger and more diverse spec-
trum of miRNA targets, the related question of how many miRNAs
are encoded by an organism’s genome becomes one of renewed
importance.
Initial attempts to characterize the miRNA repertoire of
an organism assumed that miRNAs and their precursors are
conserved (24–26), but, since then, it has become evident that
genus-specific miRNAs also exist in the fruit fly (Drosophila
melanogaster) (27), the mouse (Mus musculus) (28), and the
worm (Caenorhabditis elegans) (29). This observation suggests
that relying on conservation may underestimate an organism’s
repertoire of miRNAs. Indeed, there is no reason to think that
there will not be lineage-specific adaptive evolution in regulatory
sequences and regulatory molecules. In our earlier work, we
estimated that, if cross-genome conservation is not a required
criterion, then the repertoire of miRNAs in the human genome
likely exceeds 25,000, with an associated prediction error rate of
1% (30). A little more than 1,800 human miRNA precursors are
listed in release 20 (June 2013) of miRBase (31, 32), each giving
rise to one or two mature miRNA products. Recent analyses
using next-generation sequencing have resulted in the identifi-
cation of new human and mouse miRNAs (28, 33–37) and have
suggested the existence of tissue-specific miRNAs (33). We
reasoned that many more miRNAs are present and can be
identified through the analysis of additional samples represent-
ing more diverse tissue types.
Here, we describe our findings from such a search of pre-
viously unrecognized miRNAs that arise from the canonical
biogenesis pathway (1, 2). To this end, we examined 1,323 short
RNA-seq samples representing 13 distinct human cell types, as
well as sought corroborating evidence of loading onto the RNA-
induced silencing complex (RISC) by examining several dozen
Argonaute immunoprecipitation and sequencing (Ago CLIP-
seq) samples. Our analyses revealed the presence of 3,707 new
human miRNAs expressed throughout the genome. These
findings suggest that the repertoire of human miRNAs is larger
and more diverse than may be suggested by the publicly available
repositories. Moreover, the existence of novel miRNAs that are
primate- and tissue-specific indicates the existence of molec-
ular interactions that cannot be recapitulated by mouse models
and, thus, has potential implications for both disease and re-
search endeavors.
Results
Identification of Novel miRNAs.We deep-sequenced and generated
short RNA profiles for 100 of our own samples, which we com-
bined with an additional 1,223 public ones, to generate a collection
of 1,323 samples (Dataset S1) representing 13 distinct cell types
from both primary tissues and cell lines. The analyzed collection
comprised over 23 billion sequenced reads from short RNA-seq:
of these reads, ∼8.2 billion could be mapped unambiguously to the
human genome and were subsequently used for the identification
of novel miRNAs. Because the miRDeep2 algorithm (38, 39) has
been shown to be a sensitive and specific method for identifying
novel miRNA precursors, we used it to analyze our collection by
processing each of the 1,323 samples separately (Fig. 1). Those
identified precursors that received a miRDeep2 score of 1 or
greater were kept for further analysis. Within the span of each
retained precursor locus, we identified the most abundant miRNA
isoform (isomiR) as the corresponding mature miRNA from the
locus. To compensate for differences in sequence depth among
the various samples and select only miRNAs with statistically
significant abundance in the sample being considered, we fitted
a negative binomial distribution to the data (i.e., the abundance
data at each transcribed genomic locus) and used the abundance
of each mature miRNA to derive the miRNA’s statistical signifi-
cance within its own sample; we kept only those miRDeep2 pre-
cursor loci whose mature miRNAs had an associated false
discovery rate (FDR) of ≤ 0.05 in at least one of the analyzed
samples (Fig. 1) (PDF images of the predicted precursor struc-
tures can be downloaded by following each of the links contained
in Dataset S2 or by visiting directly https://cm.jefferson.edu/novel-
mirnas-2015/). We further postprocessed the identified mature
miRNAs and precursors to remove any predicted mature miRNA
that (i) is already represented in miRBase release 20 or in the
mirtron catalog (28) and/or (ii) colocalized with snRNAs, tRNAs,
and rRNAs even though such loci have been previously linked
with miRNA production (40–43). This filtering left us with a col-
lection of 3,494 miRNA precursors of which 213 give rise to two
mature miRNA products, one from each arm of the precursor, for
a grand total of 3,707 mature miRNAs that satisfied the FDR ≤
0.05 constraint (Dataset S2). It is worth mentioning that 91.5% of
the newly discovered mature miRNAs (3,392 of 3,707) were dis-
covered independently in at least 10 of the analyzed samples.
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Fig. 1. Flow diagram depicting the steps taken in identifying novel miRNAs.
Shown is a flow diagram of the process to identify candidate novel miRNAs
from 1,323 deep-sequencing samples using miRDeep2. Only mature miRNAwith
associated FDR ≤ 0.05 were kept for further analysis. Discovered sequences that
were present in release 20 of miRBase, or overlapped known tRNAs, snRNAs, or
rRNAs were discarded. A total of 3,707 candidate miRNAs derived from 3,494
precursor sequences were identified. Intersection of the identified miRNAs
with 43 Ago-CLIP-seq samples showed evidence of Ago loading for 1,657
newly discovered miRNAs. Sixty-six of the identified precursors produced
two miRNAs, one from each arm: one product was supported by Ago CLIP-
seq whereas the other was not.
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The Novel miRNAs Originate Throughout the Genome. The miRNAs
in release 20 of miRBase are encoded throughout the genome,
including intergenic (68.8%), exonic (4.7%), intronic (12.4%),
long noncoding (5%), and repeat regions (7.9%) (Fig. 2A). We
examined the genomic distribution of the newly discovered mature
miRNAs in an effort to investigate any potential biases. We found
that these miRNAs are distributed similarly to the existing
miRBase-cataloged miRNAs, with the majority being located within
the intergenic (57.6%) and intronic (17.4%) regions of the genome
(Fig. 2B). Several of the novel miRNAs arise from long noncoding
RNA transcripts and repeat elements in proportions that mirror
those of miRBase (Fig. 2B). Taken together, these results show that
the novel miRNAs that we have discovered have a proportional
distribution across the genome similar to those present in miRBase.
Many of the Newly Discovered miRNAs Are Expressed in a Tissue-
Specific Manner. Recent analyses revealed the presence of novel
tissue-specific miRNAs (33). To determine whether our identi-
fied miRNAs exhibit tissue-dependent expression, we normal-
ized the expression level of each miRNA as previously described
(44, 45) and separately for each sample. From each analyzed
sample, we kept only very abundant novel miRNAs [i.e., novel
miRNAs with expression levels ≥1/100 the expression of the
endogenous small nucleolar RNA (snoRNA) SNORD44 (44,
45)] and then formed the union for all samples across the 13
analyzed tissues. To compare the composition of the miRNA
populations across the different tissues, we calculated the
Jaccard similarity index between tissue i and tissue j for the novel
miRNAs: This index measures what portion of the union of
novel miRNAs that are in either tissue i or in tissue j are com-
mon to both tissues (Fig. 3A). The more tissue-specific the
miRNAs are the smaller the Jaccard index between any two
tissues. This distinction is precisely what we observed: the
novel miRNAs that we discovered in a given tissue had limited
presence outside that tissue, indicating their strong tissue-
dependent nature. For comparison purposes, we repeated this
analysis using the miRBase miRNAs that are present in the 13
tissues, instead of the newly discovered miRNAs; as can be seen
from Fig. 3B, miRBase miRNAs have a markedly lower tissue
specificity and thus much higher presence across multiple tissues.
Because the novel miRNA profiles are dependent upon the
tissue type, we next examined whether unsupervised clustering of
their expression values could cluster the samples along tissue
boundaries. To this end, we performed a principal component
analysis on rank-normalized (based on sequence depth) expression
values for our 3,707 novel miRNAs. As can be seen from Fig. 3C,
the novel miRNAs can accurately cluster lymphoblastoid cell lines
(LCLs), breast, platelets, B cells, skin, and brain tissue samples.
Taken together, these results suggest that the identified novel
miRNAs display patterns of tissue specificity and can distinguish
among tissue types.
Additional Experimental Support of the Novel miRNAs from Ago CLIP-
seq Data. MiRNAs exert their function through their association
with the Ago-silencing complex. We performed Ago CLIP-seq in
10 of our own samples: two human pancreatic cell lines (the
normal epithelial hTERT-HPNE and the metastatic MIA PaCa-2)
and four normal and four Alzheimer’s disease human brain
samples. We combined our 10 samples with an additional 33
public samples from HEK293 (46), human LCL (47), and human
brain tissue (48), and sought corroborating evidence in the form
of Ago loading for both known miRNAs (release 20 of miRBase)
and our novel miRNAs. We stress here that the 43 Ago CLIP-
seq samples we analyzed represent only 3 of the 13 tissue types
that we used during the miRNA discovery phase: Ago CLIP-seq
samples from HEK293 cells were also used, but these cells were
not represented among the 1,232 short RNA sequence samples
that were analyzed. Considering this constraint, and in con-
junction with the strong tissue-specific character of the novel
miRNAs (Fig. 3A), we do not expect to observe all of the newly
discovered miRNAs, or all of the miRBase miRNAs for that
matter, in the Ago CLIP-seq data we analyzed. Of the 2,772
miRNAs contained in miRBase release 20, 1,517 (54.7%) were
found to be present in one or more of the 43 Ago CLIP-seq
samples that we analyzed. Similarly to the miRBase miRNAs, 1,657
of our 3,707 newly discovered miRNAs (44.7%) were found in one
or more Ago CLIP-seq samples (Fig. 1, Table 1, and Dataset S2).
These results suggest that about half of our newly identified
miRNAs are loaded onto the Ago-silencing complex and thus
are imputed to be posttranscriptionally functional.
Additional Experimental Support of Novel miRNAs by a Dicer
Knockdown Experiment. For hairpin-derived miRNAs (canonical
and mirtrons), the endonuclease DICER is critically important
for the processing of precursors into mature miRNA products.
We used published RNA-seq samples from MCF7 cells before and
after siRNA knockdown of DICER (39) to determine whether the
subset of our novel miRNAs that are present in the WTMCF7 cells
show evidence of DICER dependence. Our analysis showed that
709 of the miRNAs in release 20 of miRBase and 278 of our novel
miRNAs were endogenously expressed in MCF7 cells. After siRNA
knockdown of DICER1, the miRBase miRNAs showed a median
decrease in expression of ∼2×, and our novel miRNAs showed
a median decrease in expression of ∼1.6× (Fig. 4). A similar result
A
B
Fig. 2. Both known and novel miRNAs are encoded throughout the ge-
nome. Shown are the regions of the genome from which miRNAs of miRBase
(A) and the novel miRNAs (B) are encoded. All annotations for genes [3′ UTR,
coding DNA sequence (CDS), and 5′ UTR], long noncoding RNAs (lncRNAs), and
pseudogenes are from release 72 of ENSEMBL; all repeat regions are from
RepeatMasker. Intronic regions are defined to be those segments of known
unspliced pre-mRNA that remain after removing all known genomic features
that are sense to the pre-mRNA such as exons, miRNAs, repeat elements, etc.
Intergenic regions are defined to be those segments of the genome that re-
main after removing all protein coding loci as well as all other already-char-
acterized genomic features.
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(∼1.7× decrease in expression after DICER1 knockdown) was ob-
served for those novel miRNAs that are endogenous to MCF7 cells
and show evidence of Ago loading in our Ago CLIP-seq samples.
This result indicates that those of our newly discovered miRNAs
that are endogenous to MCF7 cells are DICER-dependent and
follow the canonical biogenesis pathway.
Novel miRNAs Can Be Specifically Amplified. To further support our
findings of the novel miRNAs, we set out to specifically amplify
some of the newly discovered miRNAs in a panel of cell lines,
representing five different tissue types (breast, pancreas, pros-
tate, embryonic kidney, and fibroblasts). For these experiments,
we selected a first group of 12 novel miRNAs that, according to
our analysis, were tissue-specific and a second group of 8 novel
miRNAs that our analysis indicated were present in multiple
tissues, for a total of 20 tested novel miRNAs. We used a stem-
loop RT-PCR system (Fig. S1) similar to what has been pre-
viously described (49), and tested 20 of our novel miRNAs in 12
cell lines representing five tissue types. As can be seen in Fig. 5,
the first group of tested miRNAs indeed exhibited tissue-specific
expression patterns: Each of the 12 miRNAs was present in one
or more of the tested cell lines. As expected, the second group of
novel miRNAs was ubiquitously expressed and present in all of
the examined cell lines.
Several Abundant Novel Mature miRNAs Arise from the “Passenger”
Arms of Known miRNA Precursors. Of the 1,871 precursors in re-
lease 20 of miRBase, 898 are annotated as giving rise to a single
mature miRNA. In such instances, the corresponding precursor
arm is referred to as the “driver” arm. However, recent findings
(28, 37) suggest that miRNA products from the passenger arm
(traditionally referred to as “miRNA*” or “miRNA-star”) may
also be functionally relevant, and acting similarly to the products
from the driver arm (37, 50). This observation has rekindled in-
terest in the possibility that a double-stranded miRNA precursor
can give rise to two functional miRNA products, one from each
arm. Among the novel miRNAs that we have identified, 138
originated from the arms of miRBase miRNA precursors that as
of release 20 (June 2013) of miRBase have remained uncharac-
terized (Fig. 6 and Dataset S3). Importantly, 99 of these 138
miRNAs (71.7%) also received corroborating evidence of Ago
loading from our Ago-CLIP samples.
Many Novel miRNAs Are Seed-Paralogues of Known miRBase miRNAs.
The “seed” sequence of a miRNA (positions 2–7 inclusive from
the 5′ end) has been shown to play a pivotal role in determining
a miRNA’s set of targets (2, 10). Consequently, similarities in the
seed sequences have been taken to imply commonality among
the targeted mRNAs. With this framework in mind, we set out to
determine the composition of seed sequences of our 3,707 novel
miRNAs in relation to those annotated in miRBase and known
mirtrons. We used a strict definition for the seed as the sequence
spanning positions 2–7 inclusive from the 5′ end of the mature
miRNA and clustered all miRNAs into groups based upon this
sequence. The current release of miRBase has 2,772 annotated
miRNAs comprising 1,506 distinct seed sequences. Our set of
A
B
C
Fig. 3. Novel miRNAs display a tissue-specific pattern of expression. Shown are the Jaccard index value for the overlap of expressed miRNAs between any two
tissues for the novel miRNAs (A) and the miRBase miRNAs (B). A miRNA was considered to be expressed in each tissue if the miRNA had a normalized expression
of ≥1/100 the expression of endogenous SNORD44. (C) Principal-component analysis of the sequence data can cluster the samples based upon tissue types.
Table 1. Summary of findings for known (miRBase) and novel miRNAs
Release 20 of miRBase Our collection of novel miRNAs
No. of unique miRNAs 2,772 3,707
No. of unique precursors 1,871 3,494
No. of 3p miRNAs* 934 2,130
No. of 5p miRNAs* 940 1,577
No. of distinct seed sequences† 1,506 1,761 (888 novel seeds)
No. of Ago-CLIP supported‡ 1,517 (54.7%) 1,657 (44.7%)
*There are 898 miRNAs of miRBase (release 20) that are annotated as having only one arm.
†Seed sequence is defined as positions 2–7 inclusive from the 5′ end of the miRNA. A total of 1,763 unique seed
sequences are identified between the two sets of miRNAs.
‡A miRNA was considered Ago-CLIP–supported if it was identified in at least 1 of 43 and a minimum of 5
sequence reads (Materials and Methods).
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3,707 novel miRNAs comprised 1,761 unique seed sequences, of
which 873 are common with the seeds of miRBase miRNAs
(Dataset S4). The 873 common seeds captured 2,146 of our novel
miRNAs; the remaining 1,561 novel miRNAs had 888 distinct seed
sequences not present in an annotated miRBase miRNA (Dataset
S4). Fig. 7 shows multiple sequence alignments for the sequences of
several seed families that comprise well-characterized miRNAs,
such as miR-107/103a and miR-21, as well as instances of novel
seed clusters consisting of multiple newly discovered miRNAs.
Table S1 shows some characteristic examples of seed-paralogues
for miRNAs that are frequently cited in the literature. As can be
seen, in several instances, each of the listed known miRNAs has
multiple, currently uncharacterized, seed-paralogues among the
newly discovered miRNAs.
Several of the Newly Discovered miRNAs Are Arranged in Genomic
Clusters. The term “miRNA cluster” has been used in multiple
ways in the literature. In some instances, it is used to refer to
multiple precursors of a polycistronic transcript: e.g., the two-
miRNA cluster miR-29a/29b, the six-miRNA cluster miR-17/18/
19a/19b/20/92 (51), etc. In other instances, it is used to refer to
precursors that are genomically proximal: e.g., a few hundred
nucleotides from one another, but which could arise from dif-
ferent transcripts (e.g., miR-371/372/373). In yet other instances,
it is used to refer to a collection of precursors that are far from
one another but which, as a collection, appear as dense aggre-
gates when viewed from the standpoint of the genome (e.g., the
cluster of 49 miRNAs in 19q13.42 that spans more than 120 kb).
With these variable definitions in mind, we sought clusters that
contained two or more miRNAs, comprised either novel miRNAs
exclusively or a mix of novel and known miRNAs, were tran-
scribed from the same strand, and any two consecutive of the
miRNAs forming the cluster were separated by no more than
1,500 nt. We identified 31 such clusters, 21 of which were com-
prised exclusively of novel miRNAs (Dataset S5). When we ex-
panded the definition of a cluster to include larger regions of the
genome [such as the DLK1-D103 locus (52) on chromosome 14],
we discovered that one of our newly discovered miRNAs resides
within this locus between positions 101,506,189 and 101,506,245
(Dataset S5).
Some of the Novel miRNAs Are Antisense to Known miRNAs or to
Other Novel miRNAs. We expanded our cluster analyses to both
genomic strands, in search of potential instances of miRNAs that
were transcribed from the same genomic locus but from opposite
strands. In particular, we investigated whether any of our novel
miRNAs were antisense to either a known miRNA or to another
novel miRNA. We limited our searches to only those miRNAs
whose respective precursors directly overlapped with each other
on opposite strands and identified 13 such instances, 9 of which
comprise only novel miRNA pairs. A complete list of sense/an-
tisense pairs with the respective genomic coordinates is given
in Dataset S5.
Many of the Novel miRNAs Are Specific to the Hominidae Family of
Primates. Many of the mature miRNA products that are con-
tained in release 20 of miRBase are conserved among different
genera: e.g., the well-conserved miRNA let-7. Several exceptions
have also been reported, with the corresponding miRNAs being
genus-specific (27, 53–56). To determine the degree of conser-
vation of our novel miRNAs, we performed a search where we
sought instances not only of the mature miRNA but also of the
full-length precursor (at two different thresholds) in several
model organisms.
For this purpose, we used GLSEARCH (57) to look for the
3,494 newly identified human miRNA precursors and their
respective 3,707 mature miRNAs in the genome assemblies of
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Fig. 5. Expression of novel miRNAs in a variety of cell lines and tissue types.
Stem-loop RT-PCR experiments for 20 newly discovered miRNAs (one miRNA
per row). Each row represents a specific cell line.
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chimpanzee, gorilla, orangutan, macaque, mouse, Drosophila,
and worm. During these searches, we imposed two requirements:
(i) At least 85% of the miRNA precursor positions should be
identically present in the genome being searched, and (ii) at least
85% of the human mature miRNA sequence should be identi-
cally present in the identified orthologous precursor, including
an identically present seed. We found that 2,140 (58.1%) pre-
cursor/mature miRNA combinations were specific to humans:
i.e., they were absent from the other primates, rodents, and
invertebrates that we examined (Table 2 and Table S2). As the
phylogenetic distance from the human genome increased, we
found that progressively fewer of our novel miRNA precursors
were conserved: only 476 (12.8%) precursor/mature miRNA
combinations were shared by all of the members of the Hominidae
family of primates that we examined (Table 2). Beyond primates,
the extent of conservation of precursors and their respective ma-
ture miRNAs dropped abruptly and substantially: 109 (2.9%) of
them were present in mouse whereas none were present in the
Drosophila or worm genomes. On the other hand, using similar
criteria, we found that only 10% of the precursor/mature miRNA
combinations from miRBase were human-specific (Table 2),
suggesting that the identified novel miRNAs have a more recent
evolutionary origin. We also reran the analysis after relaxing the
conservation requirement for the precursor to a more permissive
50% (from 85%) in step i above: The results remained largely
unchanged, with the large majority of the newly identified se-
quences continuing to be primate-specific (Table S2).
These results highlight the limitations that can result from im-
posing the requirement that miRNAs be conserved across organ-
isms. Such requirements will in turn result in our missing bona fide
organism-specific miRNAs and could perhaps explain why many of
these novel miRNAs have not been previously identified.
Evaluation of the Novel miRNA Targetome. It is reasonable to as-
sume that these novel miRNAs will affect many pathways and
exert their effects on a wide range of targets. To further char-
acterize the potential targetome for this collection of novel
miRNAs, we computationally predicted their mRNA targets using
RNA22 (30, 58) to generate predictions of the mRNA targets for
each of the 3,707 newly discovered miRNAs. We opted to use
RNA22 (https://cm.jefferson.edu/rna22v2/) because of its demon-
strated ability to correctly predict targets in amino acid coding
regions and in 5′ UTRs, as well as targets that do not contain
contiguous Watson–Crick base pairs in their seed region. The
precomputed collection of targets can be downloaded from https://
cm.jefferson.edu/novel-mirnas-2015/. In Dataset S2, and in addi-
tion to the genomic and cross-genome information, we provide
separate links for each miRNA to tab-separated text files that
contain the miRNA’s collection of predicted targets. We anticipate
that this compilation will enable investigators across multiple
laboratories and help them embark on such studies. At the same
time, these predictions will also facilitate analyses across several
levels of the targetome hierarchy: from the targets of an individual
miRNA and the mRNAs collectively targeted by miRNAs with the
same seed, to the miRNAs targeting a specific pathway and to
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Fig. 6. Examples of novel mature miRNAs from previously uncharacterized arms of precursors linked to important cell processes. (A) Novel miRNA TJU_CMC.
MD2.ID00400.5p-miR arises from the 5′ arm of miR-107’s precursor (MI0000114; chr10:91,352,549-91,352,572). (B) Novel miRNA TJU_CMC.MD2.ID02736.5p-miR
arises from the 5′ end of the miR-103-a- precursor (MI0000109; chr5:2167,987,901-167,987,978). The y axis is logarithmic (base 2).
Table 2. Conservation of novel miRNA precursors
Genome where present
No. of precursor:mature
combinations for all novel
miRNAs (n = 3,707)
No. of precursor:mature
combinations for Ago
CLIP-seq (n = 1,657)
No. of precursor:mature
combinations from
miRBase (n = 2,772)
Human 3,707 (100.0%) 1,657 (100.0%) 2,772 (100.0%)
Chimpanzee 1,275 (34.3%) 543 (32.7%) 2,136 (77.1%)
Gorilla 1,321 (35.6%) 582 (35.1%) 2,303 (83.1%)
Orangutan 1,071 (28.9%) 442 (26.6%) 1,938 (69.9%)
Macaque 749 (20.2%) 327 (19.7%) 1,811 (65.3%)
Mouse 161 (4.3%) 86 (5.2%) 659 (23.7%)
Drosophila 6 (0.25%) 5 (0.3%) 4 (0.14%)
Worm 2 (0.05%) 1 (0.06%) 1 (0.03%)
Our search of other model organisms showed that both the miRBase release 20 entries and our novel miRNAs are prevalent among
primates. After a more tolerant search (Table S2), the results remain largely unchanged from what is shown here.
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previously unsuspected tissue-centered networks of interactions.
We conclude with a small example that highlights the possibili-
ties. In particular, we analyzed the targets of one set of four
miRNAs that share an identical seed sequence; the miRNAs
were miR-miR-19a, miR-19b, TJU_CMC_MD2.ID00745.5p, and
TJU_CMC_MD2.ID03086.5p. We processed our predicted tar-
gets using DAVID (59, 60) and found a broad range of signifi-
cantly enriched GO terms among them (P ≤ 0.05 and FDR ≤
0.05). Notably, and despite the shared seed sequence of these four
miRNAs, we found limited overlap between the predicted targets
(Table S3).
Discussion
In this study, we report on the discovery of 3,707 novel miRNAs
in the human genome. By comparison, there are 2,772 miRNAs
in release 20 of miRBase (61). The increasing importance of
miRNAs and their multifaceted involvement in various cellular
processes make it pressing to obtain an accurate estimate of
their numbers, to profile their patterns of expression across cell
types, and to determine their targets. To address these ques-
tions, we examined 1,323 samples, representing 13 human cell
types (Dataset S1) for the presence of novel miRNAs using the
miRDeep2 algorithm (39). By analyzing in excess of 23 billion se-
quenced reads, we identified 3,707 novel human miRNAs, each
with an associated FDR ≤ 0.05 (see Fig. 1 and Dataset S2 for
specific information on genomic location and cross-genome
conservation).
Just as protein-coding genes display tissue-specific patterns of
expression, it is reasonable to assume that miRNAs would
exhibit a similar behavior. For example, the C. elegans cel-lsy-6
miRNA is specifically expressed in the brain and controls left/
right neuronal asymmetry (62). In analogy to cel-lsy-6, the novel
miRNAs that we identified characteristically display a tissue-
specific pattern of expression, as evidenced by the low Jaccard
similarity index of the miRNAs that are expressed in pairs of
tissues (Fig. 3). This specificity was further demonstrated by in-
cluding, in the 20 miRNAs that we experimentally tested, 12
novel miRNAs that, according to our analysis, exhibited strong
tissue-specific expression patterns (Fig. 5). Additionally, (un-
supervised) principal component analysis (PCA) clustering of
our novel miRNAs showed that they are able to correctly cluster
the analyzed samples into distinct groups based upon their tissue
of origin (Fig. 3A). We note that, of our 3,707 novel miRNAs,
only 292 are in common with the miRNAs discovered by another
recently reported effort (33) that also used miRDeep2. There
are two reasons for this small overlap: first, the 1,323 samples
that we analyzed and the 94 samples analyzed in ref. 33 have only
one dataset in common (NIH GEO accession no. GSE15229;
30 samples). And second, our novel miRNAs (as evidenced by
Fig. 3A) and those discovered in ref. 33 are tissue-specific. Taken
together, these results suggest that the complete human miRNA-
ome is just beginning to be elucidated: as more studies are
performed with more varied tissue types, we expect that many
additional miRNAs will be discovered.
Both the novel miRNAs identified in our work and the miRBase
miRNAs span a wide range of expression levels. Naturally, the
expression levels of both the newly discovered and known miRNAs
change from tissue to tissue. Before determining a novel miRNA’s
expression, we made sure to compensate for the sequence depth
of the sample at hand: in particular, we used an adaptive thresh-
olding strategy that required a miRNA to be supported by a higher
number of sequence reads in samples that were more deeply se-
quenced. Generally, we found their average expression level to be
somewhat lower than that of miRBase miRNAs, in agreement with
A B
C
D
Fig. 7. Multiple sequence alignments of seed-based paralogues. The alignments shown in each panel comprise novel miRNAs and miRBase miRNAs that have
been clustered based on their shared seed sequences (red highlight). (A–C) Novel miRNAs that are previously uncharacterized seed-paralogues of known
miRNAs. (D) A new seed family consisting of 14 newly discovered miRNAs.
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previous reports (39, 54–56). We nonetheless stress that all of
the novel miRNAs that we discovered are statistically significant
(FDR ≤ 0.05) in at least one and typically in many of the analyzed
samples: as a matter of fact, 91.5% of the newly discovered miRNAs
are statistically significant in 10 or more of the processed samples.
Additionally, it is important to note that many of the novel miRNAs
are loaded onto the Ago-silencing complex, which suggests that they
are biologically active.
In the early days of the miRNA field, there was an emphasis
on identifying miRNAs that are conserved across organisms: e.g.,
let-7 first described in 2000 (63, 64). Nonetheless, species-specific
miRNAs (e.g., cel-lsy-6 in C. elegans) (62) have also been de-
scribed and characterized as have been miRNAs that are present
only in one or a few species of the same genus. Therefore, en-
forcing an organism-conservation requirement during miRNA
searches is bound to limit the number of potential miRNAs that
can be discovered, leaving organism- and lineage-specific miRNAs
undiscovered (53–56). In our effort to further characterize the
human miRNA repertoire, we liberated ourselves from the con-
servation requirement: not surprisingly then, 56.7% of our newly
discovered miRNAs are human-specific whereas 94.4% are pri-
mate-specific (Table 2). Considering that many miRNA studies to
date have focused on seeking and analyzing conserved miRNAs,
it is not surprising that, of the human miRNAs in miRBase, we
found a larger fraction to be conserved in rodents and inverte-
brates (Table 2). These findings strongly suggest the possibility of
a wide-ranging species-specific miRNA-ome that has yet to be
characterized. Indeed, it is reasonable to expect that at least some
of these novel primate-specific miRNAs participate in unexplored
aspects of regulatory processes that cannot be captured by the
currently available mouse disease models. Thus, not only could
these newly discovered miRNAs provide new molecular insights
but they could also help us define novel biomarkers for tissue or
disease states.
MiRNAs exert their function through their association with
the Argonaute complex, and, thus, those miRNAs loaded onto
Ago are expected to be capable of interacting with target RNAs.
Using 43 Ago CLIP-seq samples, 10 of which we generated
ourselves, we found evidence of Ago loading for 1,657 of the
3,707 novel miRNAs (44.7%) (Table 1). In complete analogy,
of all of the miRNAs in miRBase20, we find evidence of Ago
loading for 1,517 (54.7%): i.e., a comparable fraction, among the
43 Ago CLIP-seq samples. These seemingly moderate percent-
ages (44.7% and 54.7%, respectively) of Ago-loading support
are in fact expected, considering that the Ago CLIP-seq samples
we analyzed represent only 3 of the 13 distinct tissue types in
which we carried out the novel miRNA discovery. Consequently,
in the 43 Ago CLIP-seq samples, we expect to find support for
only a portion of the novel miRNAs that we discovered and of
those miRNAs currently in miRBase. Moreover, the lower
fraction of Ago support for the newly discovered miRNAs
(44.7% vs. 54.7%) is also expected, considering the markedly
higher degree of tissue dependence exhibited by the novel
miRNAs compared with those in miRBase (Fig. 3).
In addition to being loaded onto the Ago complex, we found
that more than 50% of our novel miRNAs were bona fide seed-
paralogues of miRNAs that are already present in miRBase
(Fig. 7, Table S1, and Dataset S4). This similarity in their seed
regions generally suggests overlapping sets of targets and shared
or related functions (65–67). Nonetheless, the remainder of the
miRNA sequence can also assist in defining the eventual tar-
getome. We examined our results of rna22-predicted targets for
two seed-paralogues of miR-19a/b. As shown in Table S3, the
predictions indicate little overlap between the GO pathways that
are enriched among the predicted targets. Although uncommon,
miRNAs with the same seed can in principle have different
targeting preferences that are dictated by variations outside of
the seed sequence (68). For example, the members of the miR-29
family share the same seed sequence but display differences in the
predicted targetomes: miR-29b localizes predominantly in the nu-
cleus whereas miR-29a and miR-29c do not (69). Furthermore,
we note that, in addition to discovering previously unsuspected
paralogues of known miRNAs, we established 888 new seeds and
their associated miRNA-seed families.
A key question of this collection of miRNAs will be to unravel
the specifics of their functional impact. The sheer magnitude of
the identified miRNAs and the very high number of predicted
targets for each such miRNA make the experimental validation
of the targetome by a single laboratory an intractable proposi-
tion. To facilitate such investigations and to assist other labo-
ratories as well as our own in embarking on such studies, we have
computationally generated candidate mRNA targets for all 3,707
novel miRNAs using RNA22 (30, 58) (for each miRNA, we
provided links in Dataset S2 and https://cm.jefferson.edu/novel-
mirnas-2015/ that give access to the RNA22-predicted targets).
One important property of RNA22 is that it is not confined on
the 3′ UTR alone but can generate predictions across the entire
length of an mRNA. Although additional experimental work will
be required to functionally validate these putative interactions, it
is reasonable to assume that a portion of these novel miRNAs
will be found to be involved in critical pathways and thus can
serve as biomarkers for disease research.
Based on the results presented here and taking into account
previous studies (28, 33), we conclude that the miRNAs cur-
rently listed in the public repositories represent only a small
fraction of the total human miRNA repertoire and that many
more human miRNAs await discovery. Our study focused on
identifying only canonical miRNAs that arise in a Dicer-dependent
fashion, and we need to keep in mind that bona fide miRNAs can
arise through other mechanisms as well (28, 70), in turn suggesting
an even larger miRNA-ome. Nonetheless, our work makes a con-
crete and very tangible contribution toward a comprehensive un-
derstanding of the human miRNA-ome, its functional relevance,
and its potential roles in disease etiology.
Materials and Methods
Makeup of the Analyzed Collection of Samples. The 1,323 samples we analyzed
represent 13 distinct cell types derived from human primary tissues [platelets,
prostate tissue, breast tissue, pancreas, B cells, serum, peripheral blood
mononuclear cells (PBMCs), gastric tissue, CD3+ lymphocytes, brain tissue,
skin tissue] and human cell lines (lymphoblastoid cell lines, the breast cell
line MCF7, and the pancreatic cell lines HPNE and MIA PaCa-2). One hundred
of these samples were collected, deep-sequenced, and analyzed by the
Computational Medicine Center of Thomas Jefferson University in the con-
text of studies approved by the Institutional Review Boards of the univer-
sities whose teams participated in this project. The remaining samples were
obtained from various public sequence data repositories. Dataset S1 pro-
vides information on all of the used samples.
RNA Sequencing. The 100 short RNA-seq samples were generated at Thomas
Jefferson University using LifeTech’s SOLiD 4 and SOLiD 5500xl sequencing
platforms. Short RNA sequence library construction, emulsion PCR, and
subsequent sequencing runs were performed following the manufacturer’s
protocols. Sequencing was performed by fragment-end sequencing of 50-nt
fragments at the Cancer Genomics Laboratory of the Kimmel Cancer Center
of Thomas Jefferson University.
Reference miRNA Database. All of the identified miRNAs were compared with
those represented in release 20 of miRBase (June 2013) (31, 32). This release
of miRBase comprises 1,871 precursor sequences and 2,772 mature miRNAs.
Additional comparisons were made to a recently identified collection of 458
mirtrons (28). It should be noted that, while we were nearing completion of
our data analyses, a new miRBase release (release 21) became publicly
available. This new version of miRBase includes only a very small (1.48%)
increase in the number of mature miRNAs (2,813 mature miRNAs). Analysis
of our collection of identified miRNAs revealed that 10 of the novel miRNAs
that we discovered were included in release 21 of miRBase. Considering the
very small increase in the number of human miRNAs that is represented by
release 21 of miRBase, we maintained our focus on release 20 of miRBase.
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Mapping of the Sequenced Reads. The short RNA sequence reads were
mapped onto the human genome assembly GRCH37 (hg19) using the Short
Read Mapping Package (SHRiMP2) (71). Before mapping, the sequence
adaptors were trimmed using cutadapt (72). All reads were quality-trimmed
using the reads’ associated quality values. During mapping, we allowed only
mismatches (replacements) that comprised no more than 4% of a given
read’s length; no insertions or deletions were permitted. Also, trimmed
reads that were shorter than 16 nt were discarded and not considered fur-
ther. Only reads that mapped unambiguously on the human genome under
these settings were kept and considered in the analysis.
Argonaute CLIP Sequencing. The hTERT-HPNE and MIA PaCa-2 cell lines
(obtained from the American Type Culture Collection or kindly provided by
Jonathan Brody, Thomas Jefferson University, Philadelphia) were propa-
gated in Dulbecco’s modified Eagle medium supplemented with 10% FBS
and 1% penicillin/streptomycin (Cellgro). Total RNA was extracted with
TRIzol reagent as per the manufacturer’s protocol (Life Technologies) and
depleted of ribosomal RNA using a RiboZero Kit (Epicentre Biotechnologies).
Ago HITS-CLIP was performed as described previously (18) with the recently
described modifications (73) to increase stringency. Briefly, cells were grown
to 70% confluency, washed once with PBS, and UV-irradiated at 254 nm for
a total energy deposition of 600 mJ/cm2 (Spectroline). RNA digestion was
carried out as per Hafner et al. (74) whereby cell lysates were treated initially
with RNase T1 at a concentration of 1 U/μL for 15 min at room temperature in
PXL buffer before coimmunoprecipitation of RNA–protein complexes on
protein A Dynabeads (Life Technologies) using the pan-Ago antibody 2A8 for
4 h at 4 °C (Millipore). Beads were then washed twice with PXL buffer and
subjected to a secondary, complete RNA digestion with 100 U/μL RNase T1 for
15 min at room temperature. After complete digestion, CLIP-RNAs were re-
leased from their on-bead protein complexes by treatment with 4 mg/mL
proteinase K and subsequent phenol/chloroform extraction as described (18).
Identification of Significantly Expressed Sample-Dependent Novel miRNAs.
Novel miRNA discovery was performed using the miRDeep2 algorithm (38)
using default settings. Each sample was processed independently (there was
no sample pooling). Only those identified hairpins with a miRDeep2 score of
1 or greater were kept for further analysis. For each sample, we identified
the end points of the mature miRNA by looking at the most prominently
expressed isomiR located within the miRDeep2 predicted mature loci. If the
identified hairpin was not at least 50 nt in length or the most prominent
isomiR was not 20–24 nt in length inclusive, we discarded the prediction.
Additionally, to eliminate noisy lowly expressed miRs, we kept a discovered
miRNA only if it had an associated FDR ≤ 0.05. To derive FDR values for each
sample, we fitted a negative binomial distribution to the available data (i.e.,
the abundance data at every transcribed genomic locus), followed by a cor-
rection for multiple testing using the Benjamini–Hochberg procedure. These
steps allow us to compensate for differences in sequence depth among the
various samples and to select only miRNAs with statistically significant
abundance in the sample being considered each time. Because we used the
abundance of each mature miRNA to derive the miRNA’s statistical signifi-
cance within its own sample, it follows that any miRNA that satisfies this FDR
level is comparatively very abundant within the samples in which it is dis-
covered. At this stage, any and all of miRDeep2’s predictions that intersected
known miRNAs, mirtrons, tRNAs, snRNAs, scRNAs, or rRNAs were excluded
from further consideration.
Because each sample was run independently, we identified hairpins and
mature coordinates with end points typically differing by 1–2 base pairs
across different samples. To compensate for this effect, overlapping hairpins
were merged into a single larger “island”, and the mature isomiR with the
highest read support across samples was determined to be the mature
miRNA. The genomic coordinates of the mature and hairpin sequences are
listed in Dataset S2. The hairpins of all discovered miRNA precursors were
inspected manually (through the PDF output generated by miRDeep2) to
ensure quality and can be downloaded from links located in Dataset S2 and
at https://cm.jefferson.edu/novel-mirnas-2015/.
Finally, we used 10 internally generated Ago-CLIP-seq samples (HPNE and
MIA PaCa-2 cells and human brain tissue) and combined them with an addi-
tional 33 public datasets from HEK293 cells (46), LCLs (47), and human brain
(48) (Dataset S1). Each mature miRNA candidate had to completely coincide
with an Ago CLIP-seq site, be observed in at least 1 of the 43 CLIP-seq samples,
and be supported by five or more unambiguously mapped CLIP-seq reads.
Seed-Based Clustering of Known and Novel Mature miRNAs. We collected the
unique seed sequences (positions 2–7 inclusive) by examining the mature
miRNAs in release 20 of miRBase (June 2013), the mature mirtrons from the
mirtron catalog (28), and our collection of novel mature miRNAs. Known and
novel miRNAs that shared the same seed formed a cluster identifiable by the
shared-seed 6-mer. All of the cluster’s members contain the same 6-mer in
positions 2–7. A novel miRNA that is in the same cluster as a known miRNA is
thus classified as a seed-paralogue of the known miRNA. Novel mature
miRNAs whose seeds are not among those of known miRNAs or mirtrons form
their own clusters and are, by definition, seed-paralogues of one another.
Genome Conservation of Hairpin and Mature miRNAs. To determine which of
the newly discovered miRNAs were conserved, we used GLSEARCH (57) and
sought the miRDeep2-identified novel miRNA hairpins and their mature
miRNA(s) in the chimpanzee, gorilla, orangutan, macaque, mouse, Drosophila,
and worm genome assemblies. During these searches, we required that (i) at
least 85% of the miRNA precursor positions be identically conserved in the
searched genome and (ii) at least 85% of the human mature miRNA positions
be identically present in the identified orthologous precursor, including an
identically present seed. Those hairpin/mature miRNA combinations that did
not meet these criteria were considered to be not conserved. We also re-
peated the search of each model genome, this time imposing a 50% identical
match for the precursor (instead of 85%).
Experimental Amplification of Novel miRNAs. To experimentally validate the
presence of the miRNAs, we specifically amplified miRNA by stem-loop
RT-PCR followed by PCR amplification of the miRNAs (49). The method is
schematically represented in Fig. S1: briefly, a stem-loop RT-PCR specific to
the last 6 nt of the 3′ end of the miRNA that is used to reverse transcribe the
miRNA along with the miRNA. The RT-PCR product is then used as a tem-
plate for PCR with a forward primer specific to the miRNA and a reverse
primer specific to the hairpin region. All reactions were performed with
50 ng of RNA and performed using standard protocols. PCR products were
designed to be 50–60 nt in length and were run on 2% agarose gels. In total,
20 novel miRNAs were tested. As a negative control, a primer to a scrambled
miRNA sequence was designed. U6 RT-PCR was performed on all samples to
control for the RNA concentrations. All primer sequences are listed in Table S4.
All PCRs were performed to 35 PCR cycles.
PCRs were performed on a panel of RNAs from 12 cell lines representing
five different tissues: breast cancer cell lines MCF-7, MCF-10A, and DCIS;
pancreas cell lines HPNE, MIA PaCa-2, and PANC-1; prostate cancer cell lines
DU145, LnCaPs, and C42; the human embryonic kidney cell line HEK293; and
two fibroblast cell lines N1 and N5 (created at Thomas Jefferson University).
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